Old Port Advisors’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-3,466
Closed -$239K 245
2025
Q2
$239K Buy
3,466
+388
+13% +$26.4K 0.07% 211
2025
Q1
$214K Sell
3,078
-616
-17% -$50.9K 0.06% 215
2024
Q4
$318K Sell
3,694
-1,400
-27% -$151K 0.09% 179
2024
Q3
$607K Buy
5,094
+233
+5% +$31.1K 0.17% 132
2024
Q2
$694K Buy
4,861
+677
+16% +$89.7K 0.21% 126
2024
Q1
$537K Buy
+4,184
New +$498K 0.16% 135

Other funds holding NVO

Old Port Advisors's NVO Position: Q3 2025 in Review

Old Port Advisors sold out of Novo Nordisk (NVO) in Q3 2025, closing a stake of 3,466 shares — an estimated $239K sold.

Old Port Advisors first reported a position in NVO in Q1 2024 and held it in 6 quarters. The position peaked at $694K in Q2 2024. 1,395 funds tracked by Wall St. Rank hold NVO as of Q3 2025.

  • Old Port Advisors reported no remaining Novo Nordisk position as of Q3 2025 after selling out during the quarter.
  • Old Port Advisors sold 3,466 Novo Nordisk shares in Q3 2025, an estimated $239K.
  • Old Port Advisors first reported a position in Novo Nordisk in Q1 2024 and held it in 6 quarters.
  • Old Port Advisors's Novo Nordisk position peaked at $694K in Q2 2024.
  • 1,395 funds tracked by Wall St. Rank held Novo Nordisk as of Q3 2025.

Based on Old Port Advisors's 13F filing for Q3 2025, filed 6 Oct 2025.